These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 18562760
1. Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI. Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JF, Kamel IR. AJR Am J Roentgenol; 2008 Jul; 191(1):285-9. PubMed ID: 18562760 [Abstract] [Full Text] [Related]
2. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF. J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611 [Abstract] [Full Text] [Related]
3. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B. Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330 [Abstract] [Full Text] [Related]
4. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF. J Comput Assist Tomogr; 2008 Apr; 32(3):347-52. PubMed ID: 18520535 [Abstract] [Full Text] [Related]
5. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging. Sahin H, Harman M, Cinar C, Bozkaya H, Parildar M, Elmas N. J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180 [Abstract] [Full Text] [Related]
6. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization. Li Z, Bonekamp S, Halappa VG, Corona-Villalobos CP, Pawlik T, Bhagat N, Reyes D, Lai H, Geschwind JF, Kamel IR. Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602 [Abstract] [Full Text] [Related]
7. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF. J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675 [Abstract] [Full Text] [Related]
8. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma. Yuan Z, Ye XD, Dong S, Xu LC, Xu XY, Liu SY, Xiao XS. Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083 [Abstract] [Full Text] [Related]
9. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N. J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261 [Abstract] [Full Text] [Related]
10. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Benndorf M, Schelhorn J, Dietzel M, Kaiser WA, Baltzer PA. Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171 [Abstract] [Full Text] [Related]
11. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer]. Yuan Z, Ye XD, Dong S, Xu LC, Sun ZC, Xiao XS. Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287 [Abstract] [Full Text] [Related]
12. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B. AJR Am J Roentgenol; 2009 Oct; 193(4):1044-52. PubMed ID: 19770328 [Abstract] [Full Text] [Related]
13. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas. Yu JS, Kim JH, Chung JJ, Kim KW. J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734 [Abstract] [Full Text] [Related]
14. Transarterial chemoembolization with drug-eluting beads preloaded with irinotecan as a first-line approach in uveal melanoma liver metastases: tumor response and predictive value of diffusion-weighted MR imaging in five patients. Venturini M, Pilla L, Agostini G, Cappio S, Losio C, Orsi M, Ratti F, Aldrighetti L, De Cobelli F, Del Maschio A. J Vasc Interv Radiol; 2012 Jul; 23(7):937-41. PubMed ID: 22720894 [Abstract] [Full Text] [Related]
15. Solitary fibrous tumor of the liver: magnetic resonance imaging evaluation and treatment with transarterial chemoembolization. El-Khouli RH, Geschwind JF, Bluemke DA, Kamel IR. J Comput Assist Tomogr; 2008 Jul; 32(5):769-71. PubMed ID: 18830108 [Abstract] [Full Text] [Related]
16. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Am J Clin Oncol; 2010 Oct; 33(5):474-80. PubMed ID: 19935383 [Abstract] [Full Text] [Related]
17. Visceral metastases from melanoma: findings on MR imaging. Premkumar A, Sanders L, Marincola F, Feuerstein I, Concepcion R, Schwartzentruber D. AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784 [Abstract] [Full Text] [Related]
18. Treatment of melanoma metastases confined to the liver and future perspectives. Vahrmeijer AL, van de Velde CJ, Hartgrink HH, Tollenaar RA. Dig Surg; 2008 Feb; 25(6):467-72. PubMed ID: 19212119 [Abstract] [Full Text] [Related]
19. Diffusion-weighted MRI of the liver-Interpretative pearls and pitfalls. Culverwell AD, Sheridan MB, Guthrie JA, Scarsbrook AF. Clin Radiol; 2013 Apr; 68(4):406-14. PubMed ID: 22981728 [Abstract] [Full Text] [Related]